With me today are Christian Henry, President and Chief Executive Officer, and James Gibson, Chief Financial Officer. On today ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue ...

Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease ...

PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results: Q4 2025Q4 2024FY 2025FY 2024Revenue (in ...

PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.

Pacific Biosciences of California, Inc. ( PACB) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST Good day, and welcome to PacBio's Fourth Quarter and Full Year 2025 Earnings Conference Call. Please ...

Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $40.4 million in its fourth quarter.

The market awaits Pacific Biosciences's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new i ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect. PacBio missed analysts’ revenue ...

SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...

Flax is a globally important crop valued for its fiber, industrial uses, and omega-3-rich oil, yet incomplete genomic information has long limited efforts to understand and improve its key traits.

• Ambev (NYSE:ABEV) is estimated to report quarterly earnings at $0.05 per share on revenue of $4.87 billion. • Genesis Energy (NYSE:GEL) is expected to report earnings for its fourth quarter. • ...